Page last updated: 2024-08-21

cupric sulfide and docetaxel anhydrous

cupric sulfide has been researched along with docetaxel anhydrous in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, L; Dong, C; Han, Y; Hu, X; Liang, S; Lin, Y; Liu, J; Lu, Y; Shi, S; Wang, C; Yao, T; Zhou, L	1

Other Studies

1 other study(ies) available for cupric sulfide and docetaxel anhydrous

Article	Year
Tumor-Targeted Drug and CpG Delivery System for Phototherapy and Docetaxel-Enhanced Immunotherapy with Polarization toward M1-Type Macrophages on Triple Negative Breast Cancers. Advanced materials (Deerfield Beach, Fla.), 2019, Volume: 31, Issue:52 Topics: Animals; Antibodies, Monoclonal, Humanized; Cell Line, Tumor; Cell Survival; Copper; Docetaxel; Drug Carriers; Folic Acid; Humans; Immunotherapy; Lasers; Mice; Nanocomposites; Oligonucleotides; Phototherapy; Polyethyleneimine; Protoporphyrins; Reactive Oxygen Species; T-Lymphocytes, Cytotoxic; Triple Negative Breast Neoplasms	2019

Article

Year

Tumor-Targeted Drug and CpG Delivery System for Phototherapy and Docetaxel-Enhanced Immunotherapy with Polarization toward M1-Type Macrophages on Triple Negative Breast Cancers.

Advanced materials (Deerfield Beach, Fla.), 2019, Volume: 31, Issue:52

Topics: Animals; Antibodies, Monoclonal, Humanized; Cell Line, Tumor; Cell Survival; Copper; Docetaxel; Drug Carriers; Folic Acid; Humans; Immunotherapy; Lasers; Mice; Nanocomposites; Oligonucleotides; Phototherapy; Polyethyleneimine; Protoporphyrins; Reactive Oxygen Species; T-Lymphocytes, Cytotoxic; Triple Negative Breast Neoplasms

2019